Pharmaceutical intervention in hypertensive patients using anlodipino

Hypertension is a chronic disease characterized by elevated blood pressure. Because it is a risk factor for important conditions such as renal failure, it should be carefully treated and controlled, and amlodipine is one of the drugs of choice for its pharmacological therapy. However, because its action occurs only in the arteries, some adverse effects may occur in the lower limbs of patients who use it. The objective was to perform the monitoring and pharmaceutical interventions in hypertensive patients using amlodipine, treated at a family health unit. Follow-up was performed in 11 patients aged 42 to 82 years old, with hypertension and anlodipine using the unit. Data were collected through interviews conducted during the pharmaceutical consultation using the pharmacotherapeutic monitoring form extracted from the Protocol of Pharmaceutical Care Practice of the State of Bahia. Drug-related problems were classified using the PWDT methodology. Most of the patients were female, non-smoker and sedentary. The most identified drug-related problem in patients correlated with the undesirable non-dose effect of amlodipine. The most frequent interventions were suspension and orientation of use. With this study it was possible to see that pharmaceutical care in the consultation and resolution of patients 'complaints, through interventions, generated the resolution of the problem with significant improvement in blood pressure and, consequently, in patients' quality of life.